BioNTech SE (BNTX) Tops Q1 EPS by EUR0.04; big revenue miss

BioNTech SE (NASDAQ: BNTX) reported Q1 EPS of (EUR0.79), EUR0.04 better than the analyst estimate of (EUR0.83). Revenue for the quarter came in at EUR167.7 million versus the consensus estimate of EUR607.8 million.

Still sees Covid-19 vaccine revenue about EUR5 billion, estimate EUR5.05 billion

For earnings history and earnings-related data on BioNTech SE (BNTX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c